Laurion Capital Management’s GH Research GHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-48,352
Closed -$338K 319
2024
Q4
$338K Hold
48,352
0.01% 242
2024
Q3
$323K Sell
48,352
-16,578
-26% -$170K ﹤0.01% 224
2024
Q2
$757K Hold
64,930
0.01% 319
2024
Q1
$692K Hold
64,930
0.01% 411
2023
Q4
$377K Hold
64,930
﹤0.01% 405
2023
Q3
$653K Hold
64,930
﹤0.01% 382
2023
Q2
$770K Hold
64,930
﹤0.01% 392
2023
Q1
$519K Sell
64,930
-250,000
-79% -$2.3M ﹤0.01% 335
2022
Q4
$3.05M Hold
314,930
0.01% 290
2022
Q3
$3.66M Hold
314,930
0.02% 279
2022
Q2
$3.14M Hold
314,930
0.05% 196
2022
Q1
$5.76M Sell
314,930
-19,662
-6% -$347K 0.07% 153
2021
Q4
$7.81M Sell
334,592
-10,408
-3% -$229K 0.08% 153
2021
Q3
$7.61M Sell
345,000
-15,000
-4% -$305K 0.03% 295
2021
Q2
$7.82M Buy
+360,000
New +$7.35M 0.04% 241

Other funds holding GHRS

Laurion Capital Management's GHRS Position: Q1 2025 in Review

Laurion Capital Management sold out of GH Research (GHRS) in Q1 2025, closing a stake of 48,352 shares — an estimated $338K sold.

Laurion Capital Management first reported a position in GHRS in Q2 2021 and held it in 15 quarters. The position peaked at $7.82M in Q2 2021. 36 funds tracked by Wall St. Rank hold GHRS as of Q1 2025.

  • Laurion Capital Management reported no remaining GH Research position as of Q1 2025 after selling out during the quarter.
  • Laurion Capital Management sold 48,352 GH Research shares in Q1 2025, an estimated $338K.
  • Laurion Capital Management first reported a position in GH Research in Q2 2021 and held it in 15 quarters.
  • Laurion Capital Management's GH Research position peaked at $7.82M in Q2 2021.
  • 36 funds tracked by Wall St. Rank held GH Research as of Q1 2025.

Based on Laurion Capital Management's 13F filing for Q1 2025, filed 15 May 2025.